NCT06655740View on ClinicalTrials.gov

Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

July 31, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

RF Vapor Ablation

RF Vapor ablation of the duodenum

Trial Locations (1)

Unknown

RECRUITING

Clinica Colonial, Santiago

Sponsors

Lead Sponsor

Aqua Medical, Inc.
All Listed Sponsors
lead

Aqua Medical, Inc.

INDUSTRY